Copyright
©2014 Baishideng Publishing Group Inc.
World J Gastrointest Endosc. Oct 16, 2014; 6(10): 457-474
Published online Oct 16, 2014. doi: 10.4253/wjge.v6.i10.457
Published online Oct 16, 2014. doi: 10.4253/wjge.v6.i10.457
Reports filed in 2014: |
(1) Food and Drug Administration. Report date: May 2, 2014. Report number: 2951238-2014-00225. (Infections or colonizations of patients following ERCP with an extended β-lactamase [ESBL] strain of E. coli strain. Also refer to Report number: 2951238-2014-00004) |
(2) Food and Drug Administration. Report date: March 7, 2014. Report number: 2518897-2014-00001[36]. (Infections or colonizations of patients following ERCP with CRE) |
(3) Food and Drug Administration. Report date: January, 28, 2014. Report number: 2951238-2014-00027[38]. (Infections or colonizations of patients following ERCP with CRE) |
(4) Food and Drug Administration. Report date: January 16, 2014. Report number: MW5033987[39]. (Infections or colonizations of patients following ERCP with CRE) |
(5) Food and Drug Administration. Report date: May 27, 2014. Report number: MW5036408. (One patient infected or colonized with CRE following ERCP) |
Reports filed in 2013: |
(1) Food and Drug Administration. Report date: March 4, 2013. Report number: MW5029305[37]. (Infections or colonizations of patients following ERCP with CRE) |
(2) Food and Drug Administration. Report date: September 30, 2013, and October 28, 2013. Report number: 2518897-2013-00005. (Also refer to Report number: 2523209-2013-00013). Note: This report was presumably filed by Hospital X documenting its CRE outbreak identified between January and September, 2013 |
Reports filed in 2012: |
(1) Food and Drug Administration. Report date: September 25, 2012. Report number: 8010047-2012-00404. (Infections or colonizations of patients following ERCP with a multidrug-resistant E. coli) |
(2) Food and Drug Administration. Report date: November 21, 2012. Report number: 8010047-2012-00454. (Possible infections or colonizations of patients following ERCP with E. coli; the bacterial strain is not necessarily resistant to antibiotics; and this incident may be a pseudo-outbreak, not true infections or colonizations) |
- Citation: Muscarella LF. Risk of transmission of carbapenem-resistant Enterobacteriaceae and related “superbugs” during gastrointestinal endoscopy. World J Gastrointest Endosc 2014; 6(10): 457-474
- URL: https://www.wjgnet.com/1948-5190/full/v6/i10/457.htm
- DOI: https://dx.doi.org/10.4253/wjge.v6.i10.457